Quantum Biopharma (QNTM) Net Income (2019 - 2026)

Quantum Biopharma (QNTM) has 8 years of Net Income data on file, last reported at $13.8 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income rose 57.37% year-over-year to $13.8 million; the trailing twelve-month figure through Mar 2026 stood at $26.0 million (up 85.29% YoY), and the FY2025 full-year result was -$27.0 million, changed N/A from the prior year.
• Net Income climbed to $13.8 million in Q1 2026, from -$2.3 million in the prior quarter.
• In the past five years, Net Income ranged from a high of $13.8 million in Q1 2026 to a low of -$9.8 million in Q1 2023.
• A 5-year average of $2.4 million and a median of $2.7 million in 2024 frame the typical range for Net Income.
• Across the five-year window, Net Income slumped 2115.35% in 2023 and jumped 317.89% in 2025, its largest moves.
• Tracing QNTM's Net Income over 5 years: stood at -$444506.0 in 2022, then sank by 646.45% to -$3.3 million in 2023, then jumped by 36.91% to -$2.1 million in 2024, then fell by 9.91% to -$2.3 million in 2025, then soared by 697.79% to $13.8 million in 2026.
• Business Quant data shows QNTM's Net Income at $13.8 million in Q1 2026, -$2.3 million in Q4 2025, and $4.7 million in Q3 2025.